The Latest Cardiac and Vascular News
MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of Lisa Giles and Robert Wills to its Board of Directors, effective October 1, 2020. Ms. Giles will serve as a member of the Audit Committee of the Board and Dr. […]
Novel perfusion monitoring system injects new precision into the treatment of peripheral artery disease and critical limb ischemia SINGAPORE, Sept. 22, 2020 /PRNewswire/ — PEDRA™ Technology, a Singapore-based developer of innovative deep-tissue perfusion monitors, today announced the completion of $4.7M Series A financing, with investors including SEEDS Capital, the investment arm of Enterprise Singapore, M&L Healthcare Investments and […]
Multi-year, 3,000 subjects study aims to detect biomarkers of early atrial transformation in atrial fibrillation CAMPBELL, Calif., Sept. 22, 2020 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare devices, announces that the University of California, San Francisco (UCSF) will be utilizing its continuous wearable ECG sensor for a 3,000 subject multi-year study on atrial […]
Company pursuing additional application for JAN101 to treat COVID-19 complications Stable formulation and engineering for JAN101 will support Phase 2b PAD Study under the FDA’s Investigational New Drug (IND) #111703, expected to begin the first quarter of 2021 Scientific Advisory Board bolstered by expert additions LAS VEGAS, Sept. 22, 2020 /PRNewswire/ — JanOne […]
SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it is strengthening its leadership team with two appointments. William Whealon, Ph.D. has joined the company as Executive Vice President of […]
An experienced executive management team is leading the way in the FDA and CE-cleared cardiac monitoring products and services arena, using smart phones and cloud-based software technology ESCONDIDO, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — via NetworkWire — CB Scientific, Inc. (OTC: CBSC) (“CBSC” or the “Company”), a provider of […]
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the worldwide leader in advanced imaging for stroke, today announced a $25 million Series B round of funding by Lennertz & Co. Building on years of profitability, these additional funds will accelerate the company’s strategic growth initiatives around the world. Founded in 2011, RapidAI makes the […]
– CE Mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology – MitraClip is a first-of-its-kind transcatheter mitral valve therapy, now on its fourth generation, improving further on MitraClip’s history as a safe and effective treatment option ABBOTT […]
Agreement expands company’s access to pulsed field ablation technology MARLBOROUGH, Mass., Sept. 21, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has signed an investment agreement with an exclusive option to acquire Farapulse, Inc., a privately-held company developing a pulsed field ablation (PFA) system for the treatment of atrial fibrillation […]
WESTMINSTER, Colo., Sept. 21, 2020 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) under the Coronavirus Treatment Acceleration Program (CTAP) to evaluate AB201 […]
